RESOLUTE-III all-comers trial: A randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention.

Trial Profile

RESOLUTE-III all-comers trial: A randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Jul 2014

At a glance

  • Drugs Zotarolimus (Primary) ; Everolimus
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms RESOLUTE-All comers; RESOLUTE-III All comers
  • Sponsors Medtronic
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 05 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 31 Jan 2014 Results published in the Journal of the American College of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top